A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 8548938)

Published in Clin Endocrinol (Oxf) on November 01, 1995

Authors

J Newell-Price1, P Trainer, L Perry, J Wass, A Grossman, M Besser

Author Affiliations

1: Department of Endocrinology, St. Bartholomew's Hospital, London, UK.

Articles citing this

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.90

Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol (2015) 1.02

Cushing's disease. Orphanet J Rare Dis (2012) 0.98

Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol (2014) 0.88

Adrenal incidentaloma: subclinical Cushing's syndrome. Postgrad Med J (1996) 0.86

Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation (2009) 0.82

Cushing's syndrome: Stepwise approach to diagnosis. Indian J Endocrinol Metab (2011) 0.82

Clinical Characteristics of Endogenous Cushing's Syndrome at a Medical Center in Southern Taiwan. Int J Endocrinol (2013) 0.81

Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome. BMJ (2005) 0.81

Cushing's syndrome: from physiological principles to diagnosis and clinical care. J Physiol (2015) 0.78

Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study. Eur J Endocrinol (2016) 0.76

Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea. Endocrinol Metab (Seoul) (2015) 0.75

Surgical management of recurrent Cushing's disease in pregnancy: A case report. Surg Neurol Int (2015) 0.75

Hair cortisol in the evaluation of Cushing syndrome. Endocrine (2017) 0.75

Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know. Int J Endocrinol (2017) 0.75

Articles by these authors

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54

RHABDOMYOSARCOMA OF THE URINARY BLADDER. Ann Surg (1939) 5.53

Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33

Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23

TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity (2001) 3.43

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32

Undergraduate medical education. BMJ (1993) 2.85

High-efficiency transformation of Chlamydomonas reinhardtii by electroporation. Genetics (1998) 2.66

Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36

Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33

A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33

Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum (1994) 2.30

Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab (2000) 2.27

Diagnosis and management of Cushing's syndrome. Lancet (1999) 2.17

Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) (2001) 2.16

Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) (1997) 2.14

Vein of Galen malformation: diagnosis and management. Neurosurgery (1987) 2.12

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev (1998) 2.06

Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody. J Immunol (1982) 1.99

Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome. Eur Arch Psychiatry Clin Neurosci (1992) 1.96

Type IV pilus biogenesis and motility in the cyanobacterium Synechocystis sp. PCC6803. Mol Microbiol (2000) 1.87

Sac1, a putative regulator that is critical for survival of Chlamydomonas reinhardtii during sulfur deprivation. EMBO J (1996) 1.83

Spontaneous thrombosis in giant intracranial aneurysms. J Neurol Neurosurg Psychiatry (1982) 1.77

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74

Helicobacter rodentium sp. nov., a urease-negative Helicobacter species isolated from laboratory mice. Int J Syst Bacteriol (1997) 1.73

Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62

Purification and biosynthesis of a derepressible periplasmic arylsulfatase from Chlamydomonas reinhardtii. J Cell Biol (1988) 1.62

An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) (1994) 1.59

Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet (1993) 1.56

Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J Virol (1992) 1.55

Stroke management: updated recommendations for treatment along the care continuum. Intern Med J (2012) 1.52

Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab (2001) 1.51

Syringomyelia with Chiari malformation; 3 unusual cases with implications for pathogenesis. Acta Neurochir (Wien) (2004) 1.51

Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48

Pendred syndrome--100 years of underascertainment? QJM (1997) 1.45

Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab (1999) 1.43

Characterization of envelope membrane polypeptides from spinach chloroplasts. J Biol Chem (1982) 1.43

Fecal proteolytic activity in clinically normal cats and in a cat with exocrine pancreatic insufficiency. J Am Vet Med Assoc (1990) 1.42

Adjustment in patients with rheumatoid arthritis and their children. J Rheumatol (1998) 1.42

The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40

Longitudinal study of adrenal steroids in a cohort of HIV-infected patients with hemophilia. J Lab Clin Med (1996) 1.40

L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide. Eur J Endocrinol (1996) 1.39

Virtuous capital: what foundations can learn from venture capitalists. Harv Bus Rev (1997) 1.39

Cytoplasmic and chloroplast synthesis of phycobilisome polypeptides. Proc Natl Acad Sci U S A (1983) 1.39

Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38

Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice. Proc Natl Acad Sci U S A (1988) 1.36

Isolation and characterization of a gene for a major light-harvesting polypeptide from Cyanophora paradoxa. Proc Natl Acad Sci U S A (1984) 1.32

Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32

Molecular characterization and evolution of sequences encoding light-harvesting components in the chromatically adapting cyanobacterium Fremyella diplosiphon. J Mol Biol (1988) 1.32

Acclimation of Chlamydomonas reinhardtii to its nutrient environment. Protist (2000) 1.29

Genomics, environmental genomics and the issue of microbial species. Heredity (Edinb) (2007) 1.28

Are certain HLA haplotypes responsible for low testosterone levels in males? Dis Markers (1989) 1.26

Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J Med Genet (1999) 1.25

Interleukin 4 expressed in situ selectively alters thymocyte development. J Exp Med (1991) 1.25

The biomechanical and histopathologic effects of surface texturing with silicone and polyurethane in tissue implantation and expansion. Plast Reconstr Surg (1992) 1.23

Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nat Genet (1996) 1.22

Breathing-control lowers blood pressure. J Hum Hypertens (2001) 1.19

Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology (1988) 1.18

Cranial venous outflow obstruction and pseudotumor Cerebri syndrome. Adv Tech Stand Neurosurg (2005) 1.18

A Golgi study of the rat dorsal lateral geniculate nucleus. J Comp Neurol (1973) 1.18

Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg (1988) 1.15

Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) (1984) 1.15

Spontaneous thrombosis of a giant intracranial aneurysm and ipsilateral internal carotid artery. Case report. J Neurosurg (1982) 1.13

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12

Targeting proteins to diatom plastids involves transport through an endoplasmic reticulum. Mol Gen Genet (1991) 1.11

Pyrroles and related compounds. XX. Syntheses of coproporphyrins. J Chem Soc Perkin 1 (1972) 1.11

Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10

Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10

Cyclosporin for central nervous system sarcoidosis. Am J Med (1988) 1.09

Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg (1993) 1.09

Levels of lead in blood and bone of women giving birth in a Boston hospital. Arch Environ Health (1996) 1.09

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf) (1991) 1.08

Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) (1984) 1.08

A novel receptor tyrosine phosphatase-sigma that is highly expressed in the nervous system. J Biol Chem (1993) 1.08

Cardiovascular risk and responsivity to mental stress: the influence of age, gender and risk factors. J Cardiovasc Risk (1996) 1.06

The participation of hypothalamic dopamine in morphine-induced prolactin release in man. Clin Endocrinol (Oxf) (1983) 1.05

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem (1997) 1.05

Sulfur availability and the SAC1 gene control adenosine triphosphate sulfurylase gene expression in Chlamydomonas reinhardtii. Plant Physiol (1996) 1.05

Evaluation of CSF shunt patency by means of technetium-99m DTPA. J Neurosurg (1982) 1.05

Isolation and characterization of a sulfur-regulated gene encoding a periplasmically localized protein with sequence similarity to rhodanese. J Bacteriol (1991) 1.04

'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int (2011) 1.03

GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab (2001) 1.03

Management of prolactinomas. Clin Endocrinol (Oxf) (1991) 1.01

Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man. Neuroendocrinology (1986) 1.01

Dependence of pancreatic integrity on adrenal and ovarian secretions. Endocrinology (1969) 1.00

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man. Br J Pharmacol (1997) 1.00

The effect of esteroproteases from mouse submaxillary gland on the growth of rat hepatoma cells in tissue culture. Exp Cell Res (1969) 0.99

Workload of a new district AIDS counselling unit, April 1987 to March 1988. Genitourin Med (1989) 0.99

Inhibition of vasopressin release in man by an opiate peptide. Lancet (1980) 0.98

Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol (2001) 0.97

Intracranial pressure changes in arrested hydrocephalus. J Neurosurg (1985) 0.97

Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide. Br J Cancer (1992) 0.97

Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation (1989) 0.97